LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation

作者：Min Xu, Peiyi Xie, Shaoqing Liu, Xukang Gao, Shiguang Yang, Zhiqiu Hu, Yue Jin Zhao, Yong Yi, Qiongzhu Dong, Christiane J. Bruns, Xiaoni Kong, Mien‐Chie Hung, Ning Ren, Chenhao Zhou · 发表于：Cancer Letters · 年份：2025 · DOI：10.1016/j.canlet.2025.217469 · 被引用次数：14 · 研究领域：Cancer, Lipids, and Metabolism、Cancer, Hypoxia, and Metabolism、Liver Disease Diagnosis and Treatment